| RS111442547 |
CACNA1C
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Long QT syndrome |
| RS111445591 |
RP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS111446464 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, Malignant hyperthermia |
| RS111447204 |
CLCC1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS111448395 |
CRX
|
Health Risk |
Conflicting classifications of pathogenicity |
Cone-rod dystrophy 2, Leber congenital amaurosis 7 |
| RS111448623 |
KRT5
|
Health Risk |
Likely pathogenic |
— |
| RS111450489 |
PKP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic right ventricular cardiomyopathy, Cardiomyopathy |
| RS111450526 |
BCAP31
|
Health Risk |
Conflicting classifications of pathogenicity |
BCAP31-related disorder, BCAP31-related disorder |
| RS111451119 |
CCDC39
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS111451684 |
COL6A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, COL6A1-related disorder |
| RS111452612 |
FLNC
|
Health Risk |
Likely pathogenic |
Hypertrophic cardiomyopathy 26, Distal myopathy with posterior leg and anterior hand involvement |
| RS111459222 |
RPGRIP1L
|
Health Risk |
Conflicting classifications of pathogenicity |
Meckel-Gruber syndrome, Joubert syndrome |
| RS111460426 |
COL7A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS111460784 |
TFAP2A
|
Health Risk |
Likely pathogenic |
Branchiooculofacial syndrome, Branchiooculofacial syndrome |
| RS111463684 |
LYST
|
Health Risk |
Conflicting classifications of pathogenicity |
Chédiak-Higashi syndrome, LYST-related disorder |
| RS111464645 |
ACTN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1AA, Primary familial hypertrophic cardiomyopathy |
| RS111466480 |
PMS2
|
Health Risk |
Likely pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS11146842 |
ABCD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS111471193 |
ENG
|
Health Risk |
Likely pathogenic |
Hereditary hemorrhagic telangiectasia, Hereditary hemorrhagic telangiectasia |
| RS111475461 |
SPG7
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 7, Hereditary spastic paraplegia |
| RS111476033 |
CYP4B1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS111476645 |
FAN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Karyomegalic interstitial nephritis, FAN1-related disorder |
| RS111477195 |
FLNC
|
Health Risk |
Likely pathogenic |
Distal myopathy with posterior leg and anterior hand involvement, Myofibrillar myopathy 5 |
| RS111481152 |
PTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Gorlin syndrome, Basal cell carcinoma |
| RS111481402 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Collagen 6-related myopathy, Bethlem myopathy 1A |
| RS111481416 |
PAX8
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypothyroidism, congenital |
| RS111481417 |
FLNA
|
Health Risk |
Pathogenic |
— |
| RS111482608 |
ABCB11
|
Health Risk |
Pathogenic/Likely pathogenic |
Benign recurrent intrahepatic cholestasis type 2, Benign recurrent intrahepatic cholestasis type 2 |
| RS111486860 |
MGAT2
|
Health Risk |
Conflicting classifications of pathogenicity |
MGAT2-congenital disorder of glycosylation, MGAT2-congenital disorder of glycosylation |
| RS111488441 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS111493987 |
KMT2C
|
Health Risk |
Conflicting classifications of pathogenicity |
Autism, susceptiblity to |
| RS111496285 |
FBN1
|
Health Risk |
Pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Marfan syndrome |
| RS111502197 |
INSR
|
Health Risk |
Conflicting classifications of pathogenicity |
Leprechaunism syndrome, Insulin-resistant diabetes mellitus AND acanthosis nigricans |
| RS111502670 |
FGB
|
Health Risk |
Likely pathogenic |
Familial dysfibrinogenemia, Familial dysfibrinogenemia |
| RS111502708 |
SALL4
|
Health Risk |
Conflicting classifications of pathogenicity |
Duane-radial ray syndrome, Inborn genetic diseases |
| RS111504036 |
PDE6B
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Congenital stationary night blindness autosomal dominant 2 |
| RS111505097 |
COL3A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS111507743 |
KIF1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 30, Neuropathy |
| RS111511993 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 4, autosomal dominant |
| RS111513627 |
TGFBR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Ehlers-Danlos syndrome |
| RS111514883 |
KANSL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Koolen-de Vries syndrome, Koolen-de Vries syndrome |
| RS111515657 |
DCHS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, DCHS1-related disorder |
| RS111516546 |
FLNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Heterotopia, periventricular |
| RS111517471 |
PKP2
|
Health Risk |
Pathogenic/Likely pathogenic |
Arrhythmogenic right ventricular dysplasia 9, Arrhythmogenic right ventricular cardiomyopathy |
| RS111517514 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Arthrogryposis multiplex congenita 6 |
| RS111520454 |
MLC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Megalencephalic leukoencephalopathy with subcortical cysts 1, Megalencephalic leukoencephalopathy with subcortical cysts 1 |
| RS111521887 |
TOLLIP
|
Health Risk |
Uncertain significance; association |
Interstitial lung disease 2, Chronic obstructive pulmonary disease |
| RS111523341 |
FN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Glomerulopathy with fibronectin deposits 2, Spondylometaphyseal dysplasia - Sutcliffe type |
| RS111525622 |
CAPN3
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2A, Autosomal recessive limb-girdle muscular dystrophy type 2A |
| RS111530469 |
MYO6
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 37, Autosomal dominant nonsyndromic hearing loss 22 |
| RS111533078 |
SDHA
|
Health Risk |
Conflicting classifications of pathogenicity |
Pheochromocytoma/paraganglioma syndrome 5, Mitochondrial complex II deficiency |
| RS111534474 |
MYO7A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 1, Autosomal dominant nonsyndromic hearing loss 11 |
| RS111534978 |
NHS
|
Health Risk |
Pathogenic |
Developmental cataract, Developmental cataract |
| RS111535594 |
TSEN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Pontocerebellar hypoplasia type 2B, Pontocerebellar hypoplasia type 2B |
| RS11153718 |
SLC35F1
|
Health Risk |
association |
Vascular endothelial growth factor (VEGF) inhibitor response, Vascular endothelial growth factor (VEGF) inhibitor response |
| RS111537259 |
SETX
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Spinocerebellar ataxia |
| RS111537544 |
LRTOMT
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS111539978 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS111540787 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Charlevoix-Saguenay spastic ataxia, Spastic paraplegia |
| RS111541229 |
GNAS
|
Health Risk |
Likely pathogenic |
— |
| RS111541487 |
B3GALNT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a |
| RS111541535 |
COX10
|
Health Risk |
Conflicting classifications of pathogenicity |
Leigh syndrome, Mitochondrial complex IV deficiency |
| RS111544757 |
GYG2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS111547156 |
MYH7
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, MYH7-related disorder |
| RS111554140 |
GATA5
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Congenital heart defects |
| RS111554790 |
FRAS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Fraser syndrome 1, FRAS1-related disorder |
| RS111556571 |
TRAPPC12
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS111558823 |
HSPG2
|
Health Risk |
Conflicting classifications of pathogenicity |
HSPG2-related disorder, HSPG2-related disorder |
| RS111567071 |
COL3A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, type 4 |
| RS111568726 |
DNAH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Spermatogenic failure 18, Ciliary dyskinesia |
| RS111569862 |
LMNA
|
Health Risk |
Pathogenic/Likely pathogenic |
Primary dilated cardiomyopathy, Charcot-Marie-Tooth disease type 2 |
| RS111570247 |
CYP27A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Cholestanol storage disease, Cardiovascular phenotype |
| RS111571762 |
CYBA
|
Health Risk |
Likely pathogenic |
Granulomatous disease, chronic |
| RS111574749 |
DNAH9
|
Health Risk |
Conflicting classifications of pathogenicity |
Ciliary dyskinesia, primary |
| RS111576740 |
TERT
|
Health Risk |
Pathogenic/Likely pathogenic |
Pulmonary fibrosis and/or bone marrow failure, Telomere-related |
| RS111580456 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group J, Fanconi anemia complementation group J |
| RS111581053 |
GJA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Syndactyly type 3, Oculodentodigital dysplasia |
| RS111583187 |
SPG11
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS111583276 |
CDH23
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 12, Usher syndrome type 1D |
| RS111584250 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Collagen 6-related myopathy, Bethlem myopathy 1A |
| RS111584802 |
POLK
|
Health Risk |
Pathogenic |
Prostate cancer, Prostate cancer |
| RS111588143 |
MYH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Aortic aneurysm, familial thoracic 4 |
| RS111588631 |
FBN1
|
Health Risk |
Pathogenic |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS111588752 |
ADSS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Myopathy, distal |
| RS111589746 |
EXT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Exostoses, multiple |
| RS111592339 |
RPS19
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia, Diamond-Blackfan anemia |
| RS111594467 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta |
| RS111595704 |
SMARCB1
|
Health Risk |
Likely pathogenic |
— |
| RS111595742 |
C3
|
Health Risk |
Likely pathogenic |
C3 DEFICIENCY, Complement component 3 deficiency |
| RS111597150 |
VWF
|
Health Risk |
Pathogenic |
Abnormality of coagulation, von Willebrand disease type 1 |
| RS111604463 |
FBN1
|
Health Risk |
Likely pathogenic |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS111604607 |
FBXO7
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Parkinsonian-pyramidal syndrome |
| RS111606207 |
CACNA1C
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Long QT syndrome |
| RS111606296 |
LEMD2
|
Health Risk |
Conflicting classifications of pathogenicity |
LEMD2-related disorder, LEMD2-related disorder |
| RS111607386 |
COL17A1
|
Health Risk |
Likely pathogenic |
— |
| RS111608902 |
TRMU
|
Health Risk |
Conflicting classifications of pathogenicity |
Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins, Inborn genetic diseases |
| RS111610925 |
PSAP
|
Health Risk |
Likely pathogenic |
Sphingolipid activator protein 1 deficiency, Sphingolipid activator protein 1 deficiency |
| RS111618622 |
TNK2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS111619594 |
TMEM67
|
Health Risk |
Conflicting classifications of pathogenicity |
Bardet-Biedl syndrome 14, modifier of |
| RS111619940 |
DLD
|
Health Risk |
Conflicting classifications of pathogenicity |
Pyruvate dehydrogenase complex deficiency, Leigh syndrome |